Pozen
-
AstraZeneca and Pozen Release Data on Osteoarthritis Drug
AstraZeneca and Pozen have announced pivotal data from two clinical trials. The data demonstrated that patients that were at risk for developing Non-Steroidal Anti-Inflammatory Drug (NSAID)-associated gastric ulcers taking Vimovo (naproxen/esomeprazo…
Pozen | 05 November 2009
-
Astrazeneca: Pozen Submits NDA For Pn400
AstraZeneca has announced that its development partner Pozen, has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Vimovo (PN400) (enteric coated naproxen /esomeprazole magnesium) tablets. It is a product th…
Pozen | 01 July 2009
